Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Ultragenyx Pharmaceutical Inc. (RARE)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Ultragenyx Pharmaceutical Inc..
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1515673.
Total stock buying since 2015: $613,250.
Total stock sales since 2015: $110,275,150.
Total stock option exercises since 2015: $13,175,837.
Table 3. Detailed insider trading at Ultragenyx Pharmaceutical Inc. (RARE) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2020-07-08 | Huizenga Theodore Alan (SVP, Controller and PAO) | Sale | 2,638 | 91.00 | 240,058 |
| 2020-07-08 | Huizenga Theodore Alan (SVP, Controller and PAO) | Option Ex | 2,000 | 21.00 | 42,000 |
| 2020-07-06 | Fust Matthew K (Director) | Sale | 6,181 | 90.00 | 556,290 |
| 2020-07-06 | Fust Matthew K (Director) | Option Ex | 6,181 | 21.00 | 129,801 |
| 2020-07-01 | Huizenga Theodore Alan (SVP, Controller and PAO) | Sale | 2,611 | 81.00 | 211,491 |
| 2020-07-01 | Huizenga Theodore Alan (SVP, Controller and PAO) | Option Ex | 1,500 | 21.00 | 31,500 |
| 2020-07-01 | Fust Matthew K (Director) | Sale | 5,000 | 85.00 | 425,000 |
| 2020-07-01 | Fust Matthew K (Director) | Option Ex | 5,000 | 21.00 | 105,000 |
| 2020-06-04 | Sharp Shalini (CFO & Executive Vice President) | Sale | 2,564 | 74.01 | 189,761 |
| 2020-06-04 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 2,564 | 48.43 | 124,174 |
| 2020-06-03 | Harris Erik (EVP & Chief Commercial Officer) | Sale | 2,516 | 74.69 | 187,920 |
| 2020-06-03 | Sharp Shalini (CFO & Executive Vice President) | Sale | 10,234 | 74.23 | 759,669 |
| 2020-06-03 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 10,234 | 48.43 | 495,632 |
| 2020-05-26 | Huizenga Theodore Alan (SVP, Controller and PAO) | Sale | 260 | 74.93 | 19,481 |
| 2020-05-19 | Sharp Shalini (CFO & Executive Vice President) | Sale | 7,128 | 73.32 | 522,624 |
| 2020-05-19 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 7,128 | 59.50 | 424,116 |
| 2020-05-18 | Parschauer Karah Herdman (EVP and General Counsel) | Sale | 2,722 | 74.72 | 203,374 |
| 2020-05-18 | Aliski William (Director) | Sale | 27,500 | 74.33 | 2,040,195 |
| 2020-05-18 | Aliski William (Director) | Option Ex | 7,500 | 40.37 | 302,775 |
| 2020-05-18 | Fust Matthew K (Director) | Sale | 1,875 | 75.00 | 140,625 |
| 2020-05-18 | Sharp Shalini (CFO & Executive Vice President) | Sale | 21,985 | 73.31 | 1,611,830 |
| 2020-05-18 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 19,593 | 70.57 | 1,382,678 |
| 2020-05-15 | Huizenga Theodore Alan (SVP, Controller and PAO) | Sale | 2,461 | 71.00 | 174,731 |
| 2020-05-15 | Huizenga Theodore Alan (SVP, Controller and PAO) | Option Ex | 1,500 | 21.00 | 31,500 |
| 2020-04-22 | Fust Matthew K (Director) | Sale | 1,875 | 65.00 | 121,875 |
| 2020-01-14 | Huizenga Theodore Alan (SVP, Controller and PAO) | Sale | 1,000 | 61.00 | 61,000 |
| 2019-09-16 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 31,843 | 3.83 | 122,117 |
| 2019-09-11 | Kakkis Emil D (President & CEO) | Buy | 5,000 | 43.63 | 218,150 |
| 2019-06-24 | Parschauer Karah Herdman (EVP and General Counsel) | Sale | 1,226 | 61.50 | 75,399 |
| 2019-06-21 | Parschauer Karah Herdman (EVP and General Counsel) | Sale | 1,489 | 63.01 | 93,821 |
| 2019-04-29 | Parschauer Karah Herdman (EVP and General Counsel) | Sale | 468 | 68.30 | 31,964 |
| 2019-03-18 | Sharp Shalini (CFO & Executive Vice President) | Sale | 14,800 | 70.00 | 1,036,000 |
| 2019-03-18 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 12,000 | 6.86 | 82,320 |
| 2019-01-02 | Huizenga Theodore Alan (VP, Controller and PAO) | Option Ex | 2,448 | 21.00 | 51,408 |
| 2018-12-07 | Aliski William (Director) | Sale | 6,000 | 49.69 | 298,140 |
| 2018-11-08 | Aliski William (Director) | Sale | 6,000 | 55.67 | 334,020 |
| 2018-10-31 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 12,000 | .81 | 9,780 |
| 2018-10-08 | Aliski William (Director) | Sale | 6,000 | 73.38 | 440,280 |
| 2018-09-25 | Sharp Shalini (CFO & Executive Vice President) | Sale | 6,700 | 90.07 | 603,469 |
| 2018-09-25 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 3,350 | .81 | 2,730 |
| 2018-08-21 | Parschauer Karah Herdman (EVP and General Counsel) | Sale | 5,000 | 78.53 | 392,650 |
| 2018-08-08 | Aliski William (Director) | Sale | 3,750 | 76.66 | 287,475 |
| 2018-06-21 | Parschauer Karah Herdman (EVP and General Counsel) | Sale | 1,226 | 82.77 | 101,476 |
| 2018-06-15 | Huizenga Theodore Alan (VP, Controller and PAO) | Sale | 955 | 83.70 | 79,933 |
| 2018-06-15 | Huizenga Theodore Alan (VP, Controller and PAO) | Option Ex | 2,955 | 21.00 | 62,055 |
| 2018-06-13 | Huizenga Theodore Alan (VP, Controller and PAO) | Sale | 1,338 | 76.97 | 102,985 |
| 2018-06-07 | Sharp Shalini (CFO & Executive Vice President) | Sale | 6,700 | 80.07 | 536,455 |
| 2018-06-07 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 3,350 | .81 | 2,730 |
| 2018-05-30 | Fust Matthew K (Director) | Sale | 6,319 | 72.00 | 454,968 |
| 2018-05-30 | Sharp Shalini (CFO & Executive Vice President) | Sale | 13,000 | 70.17 | 912,171 |
| 2018-05-30 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 6,500 | .81 | 5,297 |
| 2018-05-10 | Parschauer Karah Herdman (EVP and General Counsel) | Sale | 1,465 | 60.00 | 87,900 |
| 2018-04-19 | Aliski William (Director) | Sale | 650 | 53.97 | 35,080 |
| 2018-01-23 | Aliski William (Director) | Option Ex | 11,500 | 21.00 | 241,500 |
| 2017-08-28 | Kakkis Emil D (President & CEO) | Buy | 7,500 | 52.68 | 395,100 |
| 2017-05-26 | Huizenga Theodore Alan (VP, Controller and PAO) | Sale | 480 | 57.46 | 27,580 |
| 2017-03-09 | Huizenga Theodore Alan (Controller and PAO) | Sale | 2,500 | 86.34 | 215,844 |
| 2017-03-02 | Sharp Shalini (CFO & Executive Vice President) | Sale | 12,000 | 90.10 | 1,081,176 |
| 2017-03-02 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 12,000 | .81 | 9,780 |
| 2017-02-27 | Sharp Shalini (CFO & Executive Vice President) | Sale | 24,000 | 80.14 | 1,923,360 |
| 2017-02-27 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 24,000 | .81 | 19,560 |
| 2016-12-23 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 6,500 | .81 | 5,265 |
| 2016-11-16 | Huizenga Theodore Alan (Controller and PAO) | Sale | 2,000 | 79.73 | 159,460 |
| 2016-11-16 | Huizenga Theodore Alan (Controller and PAO) | Option Ex | 2,000 | 21.00 | 42,000 |
| 2016-11-15 | Kakkis Emil D (President & CEO) | Sale | 20,000 | 81.39 | 1,627,800 |
| 2016-11-09 | Sharp Shalini (CFO & Executive Vice President) | Sale | 24,000 | 72.51 | 1,740,192 |
| 2016-11-09 | Sharp Shalini (CFO & Executive Vice President) | Option Ex | 24,000 | .81 | 19,560 |
| 2016-10-19 | Sharp Shalini (CFO & Senior Vice President) | Sale | 12,000 | 61.34 | 736,140 |
| 2016-10-19 | Sharp Shalini (CFO & Senior Vice President) | Option Ex | 12,000 | .81 | 9,780 |
| 2016-10-14 | Kakkis Emil D (President & CEO) | Sale | 20,000 | 63.55 | 1,271,100 |
| 2016-08-15 | Kakkis Emil D (President & CEO) | Sale | 20,000 | 67.75 | 1,355,100 |
| 2016-07-21 | Agarwal Sunil (Chief Medical Officer) | Sale | 649 | 52.68 | 34,189 |
| 2016-07-15 | Kakkis Emil D (President & CEO) | Sale | 20,000 | 50.98 | 1,019,500 |
| 2016-06-20 | Agarwal Sunil (Chief Medical Officer) | Sale | 1,950 | 54.16 | 105,612 |
| 2016-05-24 | Agarwal Sunil (Chief Medical Officer) | Sale | 650 | 66.00 | 42,900 |
| 2016-05-16 | Kakkis Emil D (President & CEO) | Sale | 20,000 | 60.74 | 1,214,800 |
| 2016-04-20 | Agarwal Sunil (Chief Medical Officer) | Sale | 649 | 70.53 | 45,773 |
| 2016-04-15 | Kakkis Emil D (President & CEO) | Sale | 20,000 | 70.29 | 1,405,800 |
| 2016-03-22 | Agarwal Sunil (Chief Medical Officer) | Sale | 650 | 61.45 | 39,942 |
| 2016-01-20 | Agarwal Sunil (Chief Medical Officer) | Sale | 585 | 72.83 | 42,605 |
| 2016-01-14 | Huizenga Theodore Alan (Controller and PAO) | Option Ex | 1,000 | 21.00 | 21,000 |
| 2015-12-31 | Kakkis Emil D (President & CEO) | Sale | 5,498 | 113.78 | 625,578 |
| 2015-12-30 | Kakkis Emil D (President & CEO) | Sale | 14,502 | 114.94 | 1,666,932 |
| 2015-12-22 | Agarwal Sunil (Chief Medical Officer) | Sale | 498 | 114.81 | 57,175 |
| 2015-12-18 | Huizenga Theodore Alan (Controller and PAO) | Sale | 1,500 | 110.55 | 165,825 |
| 2015-12-18 | Huizenga Theodore Alan (Controller and PAO) | Option Ex | 1,500 | 21.00 | 31,500 |
| 2015-12-10 | Sharp Shalini (CFO & Senior Vice President) | Sale | 12,000 | 101.59 | 1,219,140 |
| 2015-12-10 | Sharp Shalini (CFO & Senior Vice President) | Option Ex | 12,000 | .81 | 9,780 |
| 2015-11-30 | Kakkis Emil D (President & CEO) | Sale | 20,000 | 98.09 | 1,961,900 |
| 2015-11-23 | Agarwal Sunil (Chief Medical Officer) | Sale | 498 | 95.88 | 47,748 |
| 2015-10-30 | Kakkis Emil D (President & CEO) | Sale | 20,000 | 99.92 | 1,998,400 |
| 2015-10-20 | Agarwal Sunil (Chief Medical Officer) | Sale | 649 | 85.51 | 55,495 |
| 2015-09-22 | Agarwal Sunil (Chief Medical Officer) | Sale | 498 | 109.51 | 54,535 |
| 2015-08-20 | Agarwal Sunil (Chief Medical Officer) | Sale | 17,020 | 110.67 | 1,883,654 |
| 2015-08-20 | Agarwal Sunil (Chief Medical Officer) | Option Ex | 10,000 | 55.88 | 558,800 |
| 2015-08-12 | Kassberg Thomas Richard (CBO & Senior Vice President) | Sale | 3,334 | 109.70 | 365,739 |
| 2015-07-27 | Aliski William (Director) | Sale | 400 | 122.58 | 49,032 |
| 2015-07-20 | Sharp Shalini (CFO & Senior Vice President) | Sale | 7,708 | 131.67 | 1,014,934 |
| 2015-07-08 | Kassberg Thomas Richard (CBO & Senior Vice President) | Sale | 3,334 | 102.12 | 340,468 |
| 2015-06-18 | Sharp Shalini (CFO & Senior Vice President) | Sale | 4,000 | 96.15 | 384,600 |
| 2015-06-17 | Huizenga Theodore Alan (Controller and PAO) | Sale | 1,500 | 94.80 | 142,200 |
| 2015-06-17 | Huizenga Theodore Alan (Controller and PAO) | Option Ex | 1,500 | 21.00 | 31,500 |
| 2015-06-10 | Kassberg Thomas Richard (CBO & Senior Vice President) | Sale | 3,334 | 88.19 | 294,025 |
| 2015-05-27 | Aliski William (Director) | Sale | 2,000 | 85.94 | 171,880 |
| 2015-05-18 | Sharp Shalini (CFO & Senior Vice President) | Sale | 4,000 | 79.43 | 317,720 |
| 2015-05-13 | Kassberg Thomas Richard (CBO & Senior Vice President) | Sale | 3,334 | 72.04 | 240,181 |
| 2015-05-12 | Aliski William (Director) | Sale | 10,500 | 68.65 | 720,825 |
| 2015-05-01 | Sharp Shalini (CFO & Senior Vice President) | Option Ex | 1,000 | .81 | 815 |
| 2015-04-20 | Sharp Shalini (CFO & Senior Vice President) | Sale | 4,000 | 61.87 | 247,460 |
| 2015-04-08 | Kassberg Thomas Richard (CBO & Senior Vice President) | Sale | 3,333 | 58.02 | 193,380 |
| 2015-03-19 | Fust Matthew K | Option Ex | 6,319 | 21.00 | 132,699 |
| 2015-03-18 | Sharp Shalini (CFO & Senior Vice President) | Sale | 4,000 | 61.45 | 245,800 |
| 2015-03-11 | Kassberg Thomas Richard (CBO & Senior Vice President) | Sale | 3,333 | 56.30 | 187,647 |
| 2015-03-03 | Huizenga Theodore Alan (Controller and PAO) | Option Ex | 2,500 | 21.00 | 52,500 |
| 2015-02-18 | Sharp Shalini (CFO & Senior Vice President) | Sale | 4,000 | 54.32 | 217,284 |
| 2015-02-11 | Kassberg Thomas Richard (CBO & Senior Vice President) | Sale | 3,333 | 54.31 | 181,021 |
| 2015-01-20 | Sharp Shalini (CFO & Senior Vice President) | Sale | 4,000 | 51.24 | 204,956 |
| 2015-01-14 | Kassberg Thomas Richard (CBO & Senior Vice President) | Sale | 3,333 | 51.51 | 171,682 |
Insider trading activities including stock purchases, stock sales, and option exercises
of RARE listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Ultragenyx Pharmaceutical Inc. (symbol RARE,
CIK number 1515673) see
the Securities and Exchange Commission (SEC) website.